News Releases

September 21, 2018 Almirall acquires Allergan U.S. medical dermatology portfolio

Additional information available on



November 30, 2015 Aqua Pharmaceuticals, LLC Announces Acquisition of Rights to VELTIN® Gel and ALTABAX® Ointment

October 26, 2015 Aqua Pharmaceuticals, LLC Announces Retirement of CEO Craig Ballaron, Promotion of Ted White to President

July 28, 2014 Aqua Pharmaceuticals, LLC Announces the U.S. Food and Drug Administration (FDA) Approval of ACTICLATE™ (doxycycline hyclate USP) Tablets, 150 mg and 75 mg

August 19, 2014 Aqua Pharmaceuticals, LLC Welcomes Nathan Mitchell As Senior Director, Marketing

June 30, 2014 Aqua Pharmaceuticals, LLC Announces Launch of Cordran® Ointment (flurandrenolide ointment, USP) 0.05%

December 17, 2013 RoundTable Healthcare Partners Announces Sale of Aqua Pharmaceuticals Holdings, Inc. to Almirall S.A.

July 25, 2013 Aqua Pharmaceuticals, LLC Welcomes Brett Fair as Vice President of Corporate Development

June 4, 2013 Aqua Pharmaceuticals Acquires Verdeso® Foam

February 18, 2013 Aqua Pharmaceuticals, LLC Announces Promotions of Key Personnel - Rich Porreca promoted to Executive Director of Sales, Roger Sharp to Director of Sales, and Bob Scott to Associate Director, Trade Relations

February 11, 2013 Aqua Pharmaceuticals, LLC Appoints Ted White as Chief Operating Officer, Mark Boyer as Director of Finance

February 5, 2013 Aqua Pharmaceuticals, LLC Co-Founder Jay Gooding Retires, Craig Ballaron Will Remain with the Company as CEO

January 17, 2012 Aqua Pharmaceuticals, LLC announces the addition of Rich Porreca as National Sales Director

January 17, 2012 Aqua Pharmaceuticals, LLC announces the addition of Steve Embry as National Sales Director

January 10, 2012 Aqua Pharmaceuticals, LLC Acquires FLUOROPLEX (fluorouracil) 1% Topical Cream®

July 25, 2011 Aqua Pharmaceuticals Welcomes Alex Iula as Director of Quality Assurance and Compliance

May 24, 2011 Aqua Pharmaceuticals Welcomes Kimberley Forbes-McKean as Vice President of Research and Development

February 1, 2011 Aqua Pharmaceuticals Acquires And Re-Launches Xolegel®

January 8, 2011 Aqua Pharmaceuticals Welcomes Ted White As Vice President, Sales

November 8, 2010 Aqua Pharmaceuticals Welcomes David Crean As Vice President, Corporate Development

November 4, 2010 Aqua Pharmaceuticals Welcomes Skip Williams As Executive Director Of Product Development

June 23, 2010 Roundtable Healthcare Partners Makes Investment In Aqua Pharmaceuticals LLC